Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights significant production growth, record revenue, and strong cash flow, indicating robust financial performance. Despite elevated costs due to expansion, the company achieved cost efficiencies and maintained a strong cash position. The Q&A session revealed positive operational progress and no major concerns from analysts. Given these factors, along with optimistic guidance and strong financial metrics, the stock price is likely to experience a positive movement in the next two weeks.
Gold equivalent production (Q4 2025) 47,178 ounces, with cash cost of $768 per ounce gold and all-in sustaining costs of $1,619 per ounce gold. The higher all-in sustaining costs were due to significant investment in the Stage 3 expansion.
Gold equivalent production (2025) 174,134 ounces, a 16% year-on-year production growth. This was achieved with cash costs of $695 per ounce and all-in sustaining costs of $1,308 per ounce, both beating guidance ranges. The increase in production was attributed to operational efficiencies and the Stage 3 expansion.
Revenue (Q4 2025) $176.8 million, a 47% increase from the same period prior year. The increase was driven by higher gold prices and increased production.
Revenue (2025) $595.2 million, a 70% increase from the prior year. This was due to record gold sales and higher average selling prices.
Cost of Sales (Q4 2025) $46.6 million compared to $32.6 million in the same period prior year. The increase was driven by higher tonnes mined and processed due to the Stage 3 expansion.
Cost of Sales (2025) $156.9 million compared to $142.2 million in the prior year. The increase was due to the ramp-up of the Stage 3 expansion, although unit costs per tonne decreased.
Cash Flow from Operating Activities (Q4 2025) $99.6 million compared to $72 million in the same period prior year. The increase was due to higher production and revenue.
Cash Flow from Operating Activities (2025) $329.3 million compared to $170.4 million in 2024. The increase was driven by record production and revenue.
Cash and Cash Equivalents (2025) $230.9 million, a record high. This was achieved despite significant investments in the Stage 3 and Stage 4 expansions.
Net Cash Position (2025) $181.6 million, a record high, reflecting strong financial performance and cost discipline.
Stage 3 Expansion Process Plant: Achieved first saleable production in October 2025 and completed commissioning in December 2025. The plant has been processing all mine feed since late October and was delivered under budget.
Stage 4 Expansion: Planned to increase production to 1.8 million tonnes per annum, producing over 400,000 ounces gold equivalent per annum, targeting startup commissioning in late 2027.
New Equipment and Infrastructure: Significant fleet upgrades, including new loaders, trucks, and drills, are planned for 2026 to support expansions. Key infrastructure projects like the paste fill plant and river crossings are progressing.
Revenue Growth: Achieved record annual revenue of $595.2 million in 2025, a 70% increase from the prior year.
Gold Selling Price: Average selling price of gold increased to $3,296 per ounce in 2025 from $2,356 in 2024.
Safety: Achieved 10 consecutive LTI-free quarters. Implemented a new integrated safety management system and received an industry ESG award for community initiatives.
Production Efficiency: Produced a record 174,134 ounces of gold equivalent in 2025, a 16% year-on-year growth. Cash costs and all-in sustaining costs were below guidance.
Operational Infrastructure: Completed key infrastructure projects like the Twin Incline and Puma Vent Incline, significantly improving underground material handling and ventilation.
Exploration Investment: Record exploration budget of $31-35 million planned for 2026, focusing on near-mine and regional prospects.
Long-term Growth: Stage 3 and Stage 4 expansions aim to transform K92 into a Tier 1 mid-tier gold producer, with production targets of 300,000 and 400,000 ounces gold equivalent per annum, respectively.
Safety and Contractor Incident: A tragic incident involving a contractor resulted in a fatality. Although mitigation measures have been implemented, this highlights potential safety risks and operational disruptions.
Elevated Costs: All-in sustaining costs have been higher than cash costs since 2023 due to significant investments in the Stage 3 expansion. While costs are expected to decline post-expansion, the current elevated costs could impact financial performance.
Operational Ramp-Up Challenges: The Stage 3 expansion and subsequent ramp-up require significant infrastructure upgrades and operational adjustments, which could pose risks to timelines and efficiency.
Power Reliability: Although improvements have been made, power reliability remains a critical factor for uninterrupted operations, especially with increased demands from expansions.
Exploration and Expansion Risks: The company is heavily investing in exploration and expansion projects, which carry inherent risks of delays, cost overruns, and failure to achieve expected resource growth.
Commodity Price Volatility: While the company has put options to protect against downside risks, fluctuations in gold and copper prices could still impact revenue and profitability.
Supply Chain and Equipment Delays: The delivery of new equipment and completion of infrastructure projects are critical for expansion. Any delays could disrupt timelines and operational efficiency.
2026 Production Guidance: Targeting production of 190,000 to 225,000 gold equivalent ounces, with production weighted towards the second half of the year as additional mining fronts come online and ramp up.
Stage 3 Expansion: Expected to support a 1.2 million tonne per annum throughput rate, producing 300,000 ounces gold equivalent per annum at that run rate. Commissioning of the process plant was completed in December 2025.
Stage 4 Expansion: Planned to increase production capacity to 1.8 million tonnes per annum, producing over 400,000 ounces gold equivalent per annum. Targeting startup commissioning in late 2027.
Growth Capital Investments for 2026: Forecasted at $100 million to $108 million, including $25 million to $28 million for Stage 3 expansion capital and $75 million to $80 million for Stage 4 expansion capital and accelerated growth projects.
Cost Guidance for 2026: Expected downward pressure on costs due to economies of scale as operations ramp up and Stage 3 expansion is completed.
Exploration Budget for 2026: A record $31 million to $35 million, representing an increase of more than 50% from 2025, focusing on near-mine and regional prospects.
Key Infrastructure Projects: Completion of several key enabler projects, including underground material handling systems, ventilation upgrades, and power station enhancements, expected to drive operational efficiencies and support expansion goals.
The selected topic was not discussed during the call.
The earnings call highlights significant production growth, record revenue, and strong cash flow, indicating robust financial performance. Despite elevated costs due to expansion, the company achieved cost efficiencies and maintained a strong cash position. The Q&A session revealed positive operational progress and no major concerns from analysts. Given these factors, along with optimistic guidance and strong financial metrics, the stock price is likely to experience a positive movement in the next two weeks.
The earnings call summary highlights strategic growth initiatives for SYFOVRE and EMPAVELI, with plans for market expansion and product development. While financial guidance is stable, new tools and education initiatives indicate a positive outlook. The Q&A session reveals optimism about market leadership and innovation, though some uncertainty exists around specific metrics. Overall, the strategic focus on growth and market expansion, coupled with a commitment to supporting patient access, suggests a positive sentiment, likely leading to a stock price increase in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.